OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy and Safety of Liraglutide and Semaglutide on Weight Loss in People with Obesity or Overweight: A Systematic Review
Zeyu Xie, Sensen Yang, Weishang Deng, et al.
Clinical Epidemiology (2022) Vol. Volume 14, pp. 1463-1476
Open Access | Times Cited: 56
Zeyu Xie, Sensen Yang, Weishang Deng, et al.
Clinical Epidemiology (2022) Vol. Volume 14, pp. 1463-1476
Open Access | Times Cited: 56
Showing 1-25 of 56 citing articles:
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zhikai Zheng, Zong Yao, Yiyang Ma, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 97
Zhikai Zheng, Zong Yao, Yiyang Ma, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 97
Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight and Cardiometabolic Parameters in Individuals With Obesity and Without Diabetes: A Systematic Review and Meta-Analysis
Huzaifa Ul Haq Ansari, Shurjeel Uddin Qazi, Faiza Sajid, et al.
Endocrine Practice (2023) Vol. 30, Iss. 2, pp. 160-171
Closed Access | Times Cited: 37
Huzaifa Ul Haq Ansari, Shurjeel Uddin Qazi, Faiza Sajid, et al.
Endocrine Practice (2023) Vol. 30, Iss. 2, pp. 160-171
Closed Access | Times Cited: 37
Semaglutide and cancer: A systematic review and meta-analysis
Lakshmi Nagendra, BG Harish, Meha Sharma, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 17, Iss. 9, pp. 102834-102834
Closed Access | Times Cited: 36
Lakshmi Nagendra, BG Harish, Meha Sharma, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 17, Iss. 9, pp. 102834-102834
Closed Access | Times Cited: 36
Molecular mechanisms of semaglutide and liraglutide as a therapeutic option for obesity
Rafael Tamayo‐Trujillo, Viviana A. Ruiz‐Pozo, Santiago Cadena-Ullauri, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 14
Rafael Tamayo‐Trujillo, Viviana A. Ruiz‐Pozo, Santiago Cadena-Ullauri, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 14
Eligibility for and practical implications of Semaglutide in overweight and obese patients with acute coronary syndrome
Vincenzo De Sio, Felice Gragnano, Antonio Capolongo, et al.
International Journal of Cardiology (2025) Vol. 423, pp. 133028-133028
Open Access | Times Cited: 1
Vincenzo De Sio, Felice Gragnano, Antonio Capolongo, et al.
International Journal of Cardiology (2025) Vol. 423, pp. 133028-133028
Open Access | Times Cited: 1
The Role of GLP1-RAs in Direct Modulation of Lipid Metabolism in Hepatic Tissue as Determined Using In Vitro Models of NAFLD
Ana G. Petrovic, Dunja Igrec, Karla Rožac, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 6, pp. 4544-4556
Open Access | Times Cited: 22
Ana G. Petrovic, Dunja Igrec, Karla Rožac, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 6, pp. 4544-4556
Open Access | Times Cited: 22
Comparison of the efficacy and safety of 10 glucagon-like peptide-1 receptor agonists as add-on to metformin in patients with type 2 diabetes: a systematic review
Zeyu Xie, Jia Hu, Hangye Gu, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 20
Zeyu Xie, Jia Hu, Hangye Gu, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 20
MASLD treatment—a shift in the paradigm is imminent
Mariana Verdelho Machado
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 18
Mariana Verdelho Machado
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 18
Impact of Selected Glucagon-like Peptide-1 Receptor Agonists on Serum Lipids, Adipose Tissue, and Muscle Metabolism—A Narrative Review
Zsolt Szekeres, András Nagy, K. Jahner, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8214-8214
Open Access | Times Cited: 7
Zsolt Szekeres, András Nagy, K. Jahner, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8214-8214
Open Access | Times Cited: 7
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Exploring Their Impact on Diabetes, Obesity, and Cardiovascular Health Through a Comprehensive Literature Review
Khalid M Hamed, Mohammed N Alosaimi, Bashaer A Ali, et al.
Cureus (2024)
Open Access | Times Cited: 7
Khalid M Hamed, Mohammed N Alosaimi, Bashaer A Ali, et al.
Cureus (2024)
Open Access | Times Cited: 7
Efficacy and safety of Mazdutide on weight loss among diabetic and non-diabetic patients: a systematic review and meta-analysis of randomized controlled trials
David Lubasi Nalisa, Nelson Cuboia, Eman Dyab, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 6
David Lubasi Nalisa, Nelson Cuboia, Eman Dyab, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 6
Use of glucagon‐like peptide‐1 receptor agonists for type 2 diabetes mellitus and outcomes of inflammatory bowel disease
Aakash Desai, Jessica C. Petrov, Jana G. Hashash, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 5, pp. 620-632
Closed Access | Times Cited: 5
Aakash Desai, Jessica C. Petrov, Jana G. Hashash, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 5, pp. 620-632
Closed Access | Times Cited: 5
Liraglutide-associated depression in a patient with type 2 diabetes: A case report and discussion
Yangliuqing He, Fenrong Liang, Yiming Wang, et al.
Medicine (2024) Vol. 103, Iss. 18, pp. e37928-e37928
Open Access | Times Cited: 4
Yangliuqing He, Fenrong Liang, Yiming Wang, et al.
Medicine (2024) Vol. 103, Iss. 18, pp. e37928-e37928
Open Access | Times Cited: 4
Effectiveness of Low Doses of Semaglutide on Weight Loss and Body Composition Among Women in Their Menopause
Joana Nicolau, Jorge Blanco-Anesto, Aina Bonet, et al.
Metabolic Syndrome and Related Disorders (2025)
Closed Access
Joana Nicolau, Jorge Blanco-Anesto, Aina Bonet, et al.
Metabolic Syndrome and Related Disorders (2025)
Closed Access
Subgroup analysis by sex and baseline BMI in people with a BMI ≥27 kg/m2 in the phase 2 trial of survodutide, a glucagon/GLP ‐1 receptor dual agonist
Carel W. le Roux, Oren Steen, Kathryn Jean Lucas, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Carel W. le Roux, Oren Steen, Kathryn Jean Lucas, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Medicines for the management of overweight and obesity: A systematic review with network meta-analysis
Gabriela Masiero Marcon, Jhonatan Mendes Paiva, Mariana Delariva Sakiyama, et al.
Brazilian Journal of Pharmaceutical Sciences (2025) Vol. 61
Open Access
Gabriela Masiero Marcon, Jhonatan Mendes Paiva, Mariana Delariva Sakiyama, et al.
Brazilian Journal of Pharmaceutical Sciences (2025) Vol. 61
Open Access
Randomised trial comparing weight loss through lifestyle and GLP-1 receptor agonist therapy in people with MASLD
Ahmad Moolla, Toryn Poolman, Nantia Othonos, et al.
JHEP Reports (2025), pp. 101363-101363
Open Access
Ahmad Moolla, Toryn Poolman, Nantia Othonos, et al.
JHEP Reports (2025), pp. 101363-101363
Open Access
Intracellular calcium channels: Potential targets for type 2 diabetes mellitus?
Jianhui Zhu, Zhenhong Pan, Dan Li
World Journal of Diabetes (2025) Vol. 16, Iss. 4
Closed Access
Jianhui Zhu, Zhenhong Pan, Dan Li
World Journal of Diabetes (2025) Vol. 16, Iss. 4
Closed Access
The Use of Liraglutide Compared to Lifestyle Modifications in Weight Reduction in Lifestyle Clinic Patients: A Systematic Review
Awwatf S. R. Alshammari, Shahad Sulaiman A. Alarfaj, Mostafa Kofi
Scientia. Technology, science and society. (2025) Vol. 2, Iss. 3, pp. 3-12
Closed Access
Awwatf S. R. Alshammari, Shahad Sulaiman A. Alarfaj, Mostafa Kofi
Scientia. Technology, science and society. (2025) Vol. 2, Iss. 3, pp. 3-12
Closed Access
Obesity and COPD: pathophysiological aspects and therapeutic perspectives
D. V. Ladnov, Н. Л. Шапорова, I. S. Khalimov
Новые Санкт-Петербургские врачебные ведомости. (2025), Iss. 4, pp. 11-19
Closed Access
D. V. Ladnov, Н. Л. Шапорова, I. S. Khalimov
Новые Санкт-Петербургские врачебные ведомости. (2025), Iss. 4, pp. 11-19
Closed Access
Knowledge, attitude and practice toward liraglutide and semaglutide among endocrinology medical staff
Bingbing Liu, Xueyi Wu, Xiaoying Zou, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Bingbing Liu, Xueyi Wu, Xiaoying Zou, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Anti‐Inflammatory Mechanisms of Antidiabetic Therapies: Metabolic Regulation and Inflammatory Pathways
Fu‐Shun Yen, Yung‐Heng Lee, P T KUO, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 4
Closed Access
Fu‐Shun Yen, Yung‐Heng Lee, P T KUO, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 4
Closed Access
Exploring Glucagon‐Like Peptide‐1 Receptor Agonists Usage Among Non‐Diabetic Healthcare Providers: A Cross‐Sectional Multi‐Country Study
Abdulqadir J. Nashwan, Hana J Abukhadijah, Karavadi Vidusha, et al.
Health Science Reports (2025) Vol. 8, Iss. 4
Open Access
Abdulqadir J. Nashwan, Hana J Abukhadijah, Karavadi Vidusha, et al.
Health Science Reports (2025) Vol. 8, Iss. 4
Open Access
The cost-effectiveness analysis of semaglutide for the treatment of adult and adolescent patients with overweight and obesity: a systematic review
Ali Sarabi Asiabar, Mohammad Ali Rezaei, Dariush Jafarzadeh, et al.
European Journal of Clinical Pharmacology (2024)
Closed Access | Times Cited: 3
Ali Sarabi Asiabar, Mohammad Ali Rezaei, Dariush Jafarzadeh, et al.
European Journal of Clinical Pharmacology (2024)
Closed Access | Times Cited: 3
Seven glucagon-like peptide-1 receptor agonists and polyagonists for weight loss in patients with obesity or overweight: an updated systematic review and network meta-analysis of randomized controlled trials
Zeyu Xie, Guimei Zheng, Zhuoru Liang, et al.
Metabolism (2024) Vol. 161, pp. 156038-156038
Closed Access | Times Cited: 3
Zeyu Xie, Guimei Zheng, Zhuoru Liang, et al.
Metabolism (2024) Vol. 161, pp. 156038-156038
Closed Access | Times Cited: 3
